MaxCyte Inc (MXCT NASDAQ) stock market data APIs
$1.4683
-0.03(-2%)
as of September 16, 2025
Try our APIs with
free plan!
MaxCyte Inc Financial Data Overview
Price chart is built with
Anychart
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Prev. Close
1.4683
Open
1.441
High
1.4964
Low
1.441
52 wk Range
1.26-5.2
Market Cap
155 M
Shares Outstanding
107 M
Revenue
35 754 K
EPS
-0.12
Beta
0.288
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MaxCyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MaxCyte Inc data using free add-ons & libraries
Get MaxCyte Inc Fundamental Data
MaxCyte Inc Fundamental data includes:
- Net Revenue: 35 754 K
- EBITDA: -49 157 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MaxCyte Inc News
New
Brooke William buys Maxcyte (MXCT) shares worth $64,500
Director William W. Brooke purchased 50,000 shares of MAXCYTE, INC. (NASDAQ:MXCT) common stock on August 13, 2025, at a price of $1.29 per share. The total value of the purchase was $64,500. Following...
Douglas buys $111k in Maxcyte shares
Director Richard Douglas recently purchased 80,000 shares of MAXCYTE, INC. (NASDAQ:MXCT) common stock, according to a Form 4 filing with the Securities and Exchange Commission. The timing is notable a...
Erck Stanley C, Maxcyte director, buys $137k in MXCT stock
Director Erck Stanley C. of MAXCYTE, INC. (NASDAQ:MXCT) purchased 100,000 shares of common stock on August 13, 2025, in a transaction valued at $137,220. The timing is notable as InvestingPro data sho...
MaxCyte (MXCT) Signed a Strategic Platform License with Adicet Bio
MaxCyte, Inc. (NASDAQ:MXCT) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, MaxCyte, Inc. (NASDAQ:MXCT) announced signing a strategic platform license with Adicet Bio, Inc. Adicet...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
